WO2001075055A3 - A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide - Google Patents
A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide Download PDFInfo
- Publication number
- WO2001075055A3 WO2001075055A3 PCT/CN2001/000520 CN0100520W WO0175055A3 WO 2001075055 A3 WO2001075055 A3 WO 2001075055A3 CN 0100520 W CN0100520 W CN 0100520W WO 0175055 A3 WO0175055 A3 WO 0175055A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- quinoprotein reductase
- human
- human quinoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU73777/01A AU7377701A (en) | 2000-03-29 | 2001-03-26 | A novel polypeptide, human quinine reductase 9 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00115266.1 | 2000-03-29 | ||
| CN00115266A CN1315529A (en) | 2000-03-29 | 2000-03-29 | Polypeptide-human quinoprotein reductase 9 and polynucleotide for coding it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001075055A2 WO2001075055A2 (en) | 2001-10-11 |
| WO2001075055A3 true WO2001075055A3 (en) | 2002-04-18 |
Family
ID=4584734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000520 Ceased WO2001075055A2 (en) | 2000-03-29 | 2001-03-26 | A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1315529A (en) |
| AU (1) | AU7377701A (en) |
| WO (1) | WO2001075055A2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998057662A2 (en) * | 1997-06-14 | 1998-12-23 | Enzacta R & D Limited | Therapeutic systems |
-
2000
- 2000-03-29 CN CN00115266A patent/CN1315529A/en active Pending
-
2001
- 2001-03-26 WO PCT/CN2001/000520 patent/WO2001075055A2/en not_active Ceased
- 2001-03-26 AU AU73777/01A patent/AU7377701A/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998057662A2 (en) * | 1997-06-14 | 1998-12-23 | Enzacta R & D Limited | Therapeutic systems |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1315529A (en) | 2001-10-03 |
| WO2001075055A2 (en) | 2001-10-11 |
| AU7377701A (en) | 2001-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001075055A3 (en) | A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide | |
| WO2001075030A3 (en) | A novel polypeptide - human tyrosinase 11 and the polynucleotide encoding said polypeptide | |
| WO2001074993A3 (en) | A novel polypeptide - human zinc finger protein 17 and the polynucleotide encoding said polypeptide | |
| WO2001079436A3 (en) | A novel polypeptide - human cell differentiation transcription factor 10 and the polynucleotide encoding said polypeptide | |
| WO2001079430A3 (en) | A novel polypeptide - human serine protease 9 and the polynucleotide encoding said polypeptide | |
| WO2001075041A3 (en) | A novel polypeptide-human epilepsy-associated protein 11 and the polynucleotide encoding said polypeptide | |
| WO2001075038A3 (en) | A novel polypeptide - human atp- dependent serine protease 9 and the polynucleotide encoding said polypeptide | |
| WO2001079429A3 (en) | A novel polypeptide - human guanine nucleotide exchange factor 10and the polynucleotide encoding said polypeptide | |
| WO2001083677A3 (en) | A novel polypeptide- human chiken limb deformity protein fh12-13 and the polynucleotide encoding said polypeptide | |
| WO2001045729A8 (en) | A novel polypeptide-human ribosomal phosphoprotein 16 and the polynucleotide encoding said polypeptide | |
| WO2001079423A3 (en) | A novel polypeptide, human bcr protein 10 and the polynucleotide encoding said polypeptide | |
| WO2001083758A3 (en) | A novel polypeptide- human dihydroorotase 8 and the polynucleotide encoding said polypeptide | |
| WO2001075045A3 (en) | A novel polypeptide - human clathrin light chain 17 and the polynucleotide encoding said polypeptide | |
| WO2001075036A3 (en) | A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide | |
| WO2001079425A3 (en) | A novel polypeptide - human chloride channel protein 10 and the polynucleotide encoding said polypeptide | |
| WO2001075016A3 (en) | A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide | |
| WO2002008427A1 (en) | A NOVEL POLYPEPTIDE- HUMAN Na+/K+ PUMP 9.57 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE | |
| WO2001075044A3 (en) | A novel polypeptide- human ribosomal protein s18-18 and the polynucleotide encoding said polypeptide | |
| WO2001083676A3 (en) | A novel polypeptide human strip-riched phosphatase 10 and the polynucleotide encoding said polypeptide | |
| WO2001075019A3 (en) | A novel polypeptide - human ataxia - telangiectasia mutein 11 andthe polynucleotide encoding said polypeptide | |
| WO2001079424A3 (en) | A novel polypeptide - human mitochondrial atpase coupling facor 6-10 and the polynucleotide encoding said polypeptide | |
| WO2001075062A3 (en) | A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide | |
| WO2001075018A3 (en) | A novel polypeptide, a human regulation factor of transcription 31 and the polynucleotide encoding the polypeptide | |
| WO2001083680A3 (en) | A novel polypeptide- human phosphoribosyl glycinamide synthase 11 and the polynucleotide encoding said polypeptide | |
| WO2001075048A3 (en) | A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |